Terumo Co. (OTCMKTS:TRUMY) Sees Large Growth in Short Interest

Terumo Co. (OTCMKTS:TRUMY - Get Free Report) saw a large increase in short interest in the month of February. As of February 28th, there was short interest totalling 20,300 shares, an increase of 37.2% from the February 13th total of 14,800 shares. Based on an average daily trading volume, of 308,900 shares, the short-interest ratio is currently 0.1 days. Approximately 0.0% of the shares of the company are short sold.

Terumo Stock Performance

Shares of TRUMY traded down $0.13 during mid-day trading on Thursday, hitting $18.61. The company's stock had a trading volume of 54,875 shares, compared to its average volume of 181,518. The stock's 50-day moving average is $18.48 and its two-hundred day moving average is $19.09. The firm has a market capitalization of $27.55 billion, a PE ratio of 38.61 and a beta of 0.60. The company has a debt-to-equity ratio of 0.12, a quick ratio of 1.70 and a current ratio of 2.94. Terumo has a one year low of $14.06 and a one year high of $21.22.

Terumo (OTCMKTS:TRUMY - Get Free Report) last issued its quarterly earnings results on Thursday, February 13th. The company reported $0.16 earnings per share for the quarter. The company had revenue of $1.73 billion during the quarter.

Terumo Company Profile

Terumo Corporation engages in the manufacture and sale of medical products and equipment in Japan, Europe, China, the United States, Asia, and internationally. The company operates through three segments: Cardiac and Vascular Company, Medical Care Solutions Company, and Blood and Cell Technologies Company.